Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takehiro Nakao
Institution:
National Cancer Center Hospital East
Observed institutions:
Noritake (Japan),
The Cancer Institute Hospital,
National Cancer Center Hospital East,
Japanese Foundation For Cancer Research
ORCID:
0009-0008-4421-0997
Observed ORCID:
0009-0008-4421-0997
OpenAlex ID:
A5004432102
39.4: Large Size FED with Carbon Nanotube Emitter
2002
·
Sashiro Uemura
, Junko Yotani
, et al.
·
SID Symposium Digest of Technical Papers
·
41
Large‐area FEDs with carbon‐nanotube field emitter
2003
·
Sashiro Uemura
, Junko Yotani
, et al.
·
Journal of the Society for Information Display
·
36
Emission Enhancement by Excimer Laser Irradiation over a Weblike Carbon Nanotube Layer
2004
·
Junko Yotani
, Sashiro Uemura
, et al.
·
Japanese Journal of Applied Physics
·
21
Uniform carbon‐nanotube emitter for field‐emission displays
2005
·
Hiroyuki Kurachi
, Sashiro Uemura
, et al.
·
Journal of the Society for Information Display
·
16
19.3: CNT‐FED for Character Displays
2004
·
Junko Yotani
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
12
24.3: Improvement of CNT‐ FED Characteristics
2003
·
Junko Yotani
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
9
Practical CNT‐FED structure for high‐luminance character displays
2008
·
Junko Yotani
, Sashiro Uemura
, et al.
·
Journal of the Society for Information Display
·
7
Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
·
Clinical Cancer Research
·
6
Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report
2024
·
Tetsuya Urasaki
, Makiko Ono
, et al.
·
Oncology Letters
·
6
PDF
Formation of Secondary Thin Carbon Nanotubes on Thick Ones and Improvement in Field-Emission Uniformity
2006
·
Hiroyuki Kurachi
, Sashiro Uemura
, et al.
·
Japanese Journal of Applied Physics
·
6
PDF
59.3: High‐Resolution CNT‐FED for Graphic Displays
2005
·
Junko Yotani
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
6
6.2: Distinguished Paper : Improvements of Color CNT‐FED Character‐Displays
2009
·
Sashiro Uemura
, Hiroyuki Kurachi
, et al.
·
SID Symposium Digest of Technical Papers
·
3
High‐luminance 1.8‐mm‐pixel‐pitch CNT‐FED for ubiquitous color character displays
2009
·
Junko Yotani
, Sashiro Uemura
, et al.
·
Journal of the Society for Information Display
·
3
13.1: High‐Luminance 1.8mm‐Pitch CNT‐FED for Ubiquitous Color Character Displays
2008
·
Junko Yotani
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
3
37.2: Distinguished Paper : Practical CNT‐FED Structure for High‐Luminance Character‐Displays
2007
·
Junko Yotani
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
3
High Resolution CNT-FED and Improvement in Field-Emission Characteristics
2007
·
Hiroyuki Kurachi
, Sashiro Uemura
, et al.
·
IEEJ Transactions on Sensors and Micromachines
·
3
PDF
Carbon nanotube FED for high luminance character display
2009
·
Sashiro Uemura
, Hiroyuki Kurachi
, et al.
·
International Vacuum Nanoelectronics Conference
·
2
52.4: Formation of Secondary Thin CNTs on Thick CNTs for FED Emitters
2006
·
Hiroyuki Kurachi
, Sashiro Uemura
, et al.
·
SID Symposium Digest of Technical Papers
·
2
Supplementary Figure S5 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S1 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Data from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S4 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Table S1 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Supplementary Figure S3 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
2026
·
Kenichi Harano
, Takehiro Nakao
, et al.
Show more works
View as search
Works count:
27
Citation count:
185
H-index:
7
I10-index:
5
Year
Topic
Type